Akari Therapeutics plc ADS (AKTX)
AKTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.90
-7.49% on the day
Market cap
$18.1M
Nano cap
Revenue · 2023
$368K
No prior year to compare
Net income · 2023
-$10.0M
-2720.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2023.
Profile
| Field | Value |
|---|---|
| Ticker | AKTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United Kingdom |
| IPO year | Not reported by the screener |
| SEC CIK | 0001541157 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | X0 |
Financials · 2023
| Line | Value |
|---|---|
| Revenue | $368K |
| Net income | -$10.0M |
| Operating income | -$16.8M |
| Net margin | -2720.5% |
| Operating margin | -4568.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $3.8M |
| Total assets | $4.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 49.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-07-02 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-01 |
| Latest proxy | DEF 14A | 2026-10-01 |
Source: SEC EDGAR submissions feed, 733 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NEUP | Neuphoria Therapeutics Inc. | $3.39 | +2.11% | $18.3M |
| RADX | Radiopharm Theranostics Limited | $1.20 | +8.10% | $17.3M |
| NCEL | NewcelX Ltd. | $2.84 | -2.20% | $16.4M |
| QNRX | Quoin Pharmaceuticals Ltd. | $4.15 | -4.82% | $19.9M |
| OPTH | Optimi Health Corp. Common Shares | $3.50 | -3.58% | $20.0M |
| COCP | Cocrystal Pharma Inc. | $1.08 | +1.89% | $20.8M |
| MRKR | Marker Therapeutics Inc. | $0.9249 | -8.43% | $15.4M |
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier